Abstract
AbstractThe antioedematogenic activity of two natural pregnane compounds from Mandevilla velutina was evaluated against croton oil‐induced ear oedema in mice. For comparison the effects of nonsteroidal (indomethacin, phenidone and BW 755C) and steroidal (dexamethasone) antiinflammatory drugs were analysed. The purified compounds from M. velutina MV8612 (3 and 30 mg/kg, i.p.) and to a lesser extent MV8608 (30 and 100 mg/kg; i.p.), given 30 min prior to the croton oil, significantly inhibited this oedema, maximal inhibition (MI) of 53% and 26%, respectively. However, given orally 180 min after, neither compound had any effect. Compound MV8612 but not MV8606 (200–600 μg/ear) given 180 min after the irritant significantly inhibited croton oil‐induced oedema, MI of 29%. Indomethacin given topically (0.05–0.2 mg/ear) 180 min after, but not orally (1–10 mg/kg), significantly inhibited this oedema, MI of 30%, while phenidone administered either orally (100 and 300 mg/kg) or topically (2 mg/ear) 180 min after caused partial inhibition, MI of 24% and 18%, respectively. BW 755C, given topically (0.1 and 0.5 mg/ear) but not orally (10–300 mg/kg) 180 min after, was also effective in inhibiting croton oil oedema, MI of 18%. Dexamethasone given either topically (0.05–0.2 mg/ear) or orally (0.25‐1 mg/kg) 30 and 60 min prior potently inhibited croton oil oedema, MI of 86% and 79%, respectively. These results indicate that the natural compounds MV8612 and to a lesser extent MV8608 isolated from M. velutina, besides their antibradykinin activity, exhibited both topical and systemic long‐lasting antioedematogenic effects against croton oil‐induced ear oedema in mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.